Mark R. GoldschmidtfnA.
February 1, 2002
Introduction
¶5
"put the public in possession of what the party claims as his own invention, so as to ascertain if he claims anything that is in common use, or is already known, and to guard against prejudice or injury from the use of an invention which the party may otherwise innocently suppose not to be patented. It is, therefore, for the purpose of warning an innocent purchaser or other person using a machine, of his infringement of the patent; and at the same time of taking from the inventor the means of practicing upon the credulity or the fears of other persons, by pretending that his invention is more than what it really is, or different from its ostensible objects, that the patentee is required to distinguish his invention in his specification."26
"[n]ot having been specifically named or mentioned in any manner, one is left to select from the myriads of possibilities encompassed by the broad disclosure, with no guide indicating or directing that this particular selection should be made rather than any of the many others which could also be made."47
¶10
"First, it presumes some motivation for wanting to make the compound in preference to others. While we have no doubt a person so motivated would be enabled by the specification to make it, this is beside the point for the question is not whether he would be so enabled but whether the specification discloses the compound to him, specifically, as something appellants actually invented. We think it does not. Second, we doubt that the rejection is truly based on section 112, at least on the parts relied on by appellants [i.e. the enablement requirement]. If based on section 112, it is on the requirement thereof that ‘The specification shall contain a written description of the invention . . . .’"49
"[C]onsider the case where the specification discusses only compound A and contains no broadening language of any kind. This might very well enable on skilled in the art to make and use compounds B and C; yet the class consisting of A, B, and C has not been described."52
"[a]dequate description of the invention guards against the inventor's overreaching by insisting that he recount his invention in such detail that his future claims can be determined to be encompassed with his original creation. The definiteness requirement shapes the future conduct of persons other than the inventor, by insisting that they receive notice of the scope of the patented device."61
¶15
"An adequate written description of a DNA requires more than a statement that it is part of the invention and reference to a potential method for isolating; what is required is a description of the DNA itself. Revel's specification does not do that. Revel's application does not even demonstrate that the disclosed method actually leads to the DNA, and thus that he had possession of the invention . . . . A bare reference to DNA with a statement that it can be obtained by reverse transcription is not a description; it does not indicate that Revel was in possession of the DNA . . . . [S]uch a disclosure just represents a wish, or arguably a plan, for obtaining the DNA."85
¶20
¶25
An element in a claim for a combination may be expressed as a means or step for performing a specified function without recital of structure, material, or acts in support thereof, and such claim shall be construed to cover the corresponding structure, material, or acts described in the specification and equivalents thereof.
| [A] | The author is a member of the BOSTON COLLEGE INTELLECTUAL PROPERTY AND TECHNOLOGY FORUM and is a Managing Editor for the BOSTON COLLEGE ENVIRONMENTAL AFFAIRS LAW REVIEW. |
| [1] | Vas-Cath Inc. v. Mahurkar, 935 F.2d 1555, 1560 (Fed. Cir. 1991) |
| [2] | In re Smith, 481 F.2d 910, 914 (C.C.P.A. 1973). |
| [3] | Robert P. Merges, Peter S. Menell & Mark A. Lemley, Intellectual Property in the New Technological Age 217 (2d ed. 2000). |
| [4] | See 35 U.S.C. § 112 (1994); Appendix A. |
| [5] | See 35 U.S.C. § 112, para. 1; Appendix A. |
| [6] | See Bonito Boats Inc. v. Thunder Craft Boats Inc., 489 U.S. 141, 150-51 (1989). |
| [7] | Donald S. Chisum, Chisum on Patents § 7.01 (2000); see also Appendix A. |
| [8] | See Appendix A. |
| [9] | In re Wertheim, 541 F.2d 257 (C.C.P.A. 1976). |
| [10] | Chisum, supra note 7, § 7.04. |
| [11] | Vas-Cath Inc. v. Mahurkar, 935 F.2d 1555, 1560 (Fed. Cir. 1991). |
| [12] | See id. |
| [13] | Id. The court in Vas-Cath Inc. also stated that the issue of adding claims at a later time in the hope of gaining the protection of the earlier filing date has also been analyzed in terms of "new matter" under 35 U.S.C. section 132. Id. |
| [14] | Chisum, supra note 7, at § 7.04. |
| [15] | See Vas-Cath Inc., 935 F.2d at 1562-63; In re Wright, 866 F.2d 422, 424-25 (Fed. Cir. 1989); Rengo Co. v. Molins Mach. Co., 657 F.2d 535, 551 (3rd Cir. 1981). |
| [16] | Vas-Cath Inc., 935 F.2d at 1560. This paper will not discuss in detail the written description issue in an interference context. |
| [17] | See Appendix A; see also Vas-Cath Inc., 935 F.2d at 1560. |
| [18] | Vas-Cath Inc., 935 F.2d at 1560-61 (refering to Evans v. Eaton, 20 U.S. 356 (1822)). |
| [19] | Chisum, supra note 7, at § 7.02 (citing the Patent Act of April 10, 1790, ch. 7, § 2, 1 Stat. 109). |
| [20] | Id. |
| [21] | Evans v. Eaton, 20 U.S. 356, 365 (1822). |
| [22] | Id. (emphasis added); see also Vas-Cath Inc., 935 F.2d at 1560-61. |
| [23] | Evans, 20 U.S. at 366. |
| [24] | Id. at 434. |
| [25] | Id. |
| [26] | Id. |
| [27] | Id. at 435; see also O'Reilly v. Morse, 45 U.S. 62, 68 (1853) (relying on the enablement requirement to invalidate Morse's eighth claim; however it could be argued the Court implicitly also relied on the written description requirement in making its determination). |
| [28] | Chisum, supra note 7, § 7.02[4]; see Appendix A. |
| [29] | The United States Court of Appeals for the Federal Circuit was created by Congress in 1982 to hear all patent appeals from the federal District Courts and is the successor to the the Court of Customs and Patent Appeals (C.C.P.A.). See Merges et al., supra note 3, at 129-30. |
| [30] | See Vas-Cath Inc. v. Mahurkar, 745 F. Supp. 517, 522 (N.D. Ill. 1990). |
| [31] | Id. |
| [32] | See generally Vas-Cath Inc. v. Mahurkar, 935 F.2d 1555 (Fed. Cir. 1991). |
| [33] | Id. at 1563. |
| [34] | Id.; see also Gentry Gallery, Inc. v. The Berkline Corp., 134 F.3d 1473 (Fed. Cir. 1998); Regents of the University of California v. Eli Lilly & Co., 119 F.3d 1559 (Fed. Cir. 1997). |
| [35] | Markman v. Westview Instruments, Inc., 517 U.S. 370, 373 (1996) (referring to the Doctrine of Equivalents). |
| [36] | Id. at 378, 116 S.Ct. at 1390. |
| [37] | Id. (citing Act of July 4, 1836, ch. 357, § 6, 5 Stat. 119). |
| [38] | Id. |
| [39] | Id. (citing Act of July 8, 1870, ch. 230, § 26, 16 Stat. 201). |
| [40] | Id. at 1116-17. |
| [41] | 379 F.2d 990 (C.C.P.A. 1967); see also Chisum, supra note 5, at § 7.04[1]. |
| [42] | In re Ruschig, 379 F.2d at 996. |
| [43] | Id. at 991. |
| [44] | Id. at 993-94. |
| [45] | Id. at 991. |
| [46] | Id. |
| [47] | Id. at 995. |
| [48] | In re Ruschig, 379 F. 2d at 995. |
| [49] | Id. at 995 (emphasis added). |
| [50] | Id. at 996. |
| [51] | In re DiLeone, 436 F.2d 1404 (C.C.P.A. 1971). |
| [52] | Id. at 1405 n. 1. |
| [53] | See Kennecott Corp. v, Kyocera Int'l, Inc., 835 F.2d 1419, 1421 (Fed. Cir. 1987). |
| [54] | Id. |
| [55] | 935 F.2d 1555, 1563-64 (Fed. Cir. 1991). |
| [56] | Id. (emphasis added). |
| [57] | See Appendix A; see generally Rengo Co. Ltd. v. Molins Mach. Co., 657 F.2d 535, 550 (3d Cir. 1981). |
| [58] | See Appendix A. |
| [59] | 657 F.2d at 550-51. |
| [60] | Id. |
| [61] | Id. |
| [62] | Id. at 551. |
| [63] | Ralston Purina Co. v. Far-Mar-Co., Inc., 772 F.2d 1570, 1574-75 (Fed. Cir. 1985). |
| [64] | Id. at 1575; see also Vas-Cath Inc. v. Mahurkar, 935 F.2d 1555, 1565 (Fed. Cir. 1991) (holding that under certain circumstances, drawings alone may provide sufficient written decription). |
| [65] | See Ralston Purina Co., 772 F.2d at 1574-77 (relying on known industry standards). |
| [66] | 650 F.2d 1212, 1214 (C.C.P.A. 1981) |
| [67] | Id. at 1215. |
| [68] | Ex parte Sorenson, 3 U.S.P.Q.2d 1462, 1463 (P.T.O. Bd. Pat. App. & Int'f 1987). |
| [69] | Id. |
| [70] | Id. |
| [71] | In re Smythe, 480 F.2d 1376, 1384 (C.C.P.A. 1973). |
| [72] | See id. at 1384. |
| [73] | Id. |
| [74] | See id. |
| [75] | See id. |
| [76] | See id. at 1382-84. |
| [77] | Gentry Gallery, Inc. v. Berkline Corp., 134 F.3d 1473, 1479 (Fed. Cir. 1998). |
| [78] | Id. at 1475. |
| [79] | Id. at 1479. |
| [80] | See id. |
| [81] | 107 F.3d 1565, 1572 (Fed. Cir. 1997); see also Regents of the University of California v. Eli Lilly & Co., 119 F.3d 1559, 1568 (Fed. Cir. 1997) (stating that the case law does “not compel the conclusion that a description of a species always constitutes a description of a genus of which it is part”). |
| [82] | See Lockwood, 107 F.3d at 1572. |
| [83] | Fiers v. Revel, 984 F.2d 1164, 1169 (Fed. Cir. 1993) |
| [84] | Id. at 1166-67. |
| [85] | Id. at 1170-71. |
| [86] | See In re Wertheim, 541 F.2d 257, 263-64 (C.C.P.A. 1976) |
| [87] | Id. at 264-65; see also Chisum, supra note 7, § 7.04[2]; Regents of the University of California v. Eli Lilly & Co., 119 F.3d 1559, 1568 (Fed. Cir. 1997) (stating that the description requirement of the patent statute requires a description of an invention, not an indication of a result that one might achieve if one made that invention); In re Kaslow, 707 F.2d 1366 (Fed. Cir. 1983) (stating that the description requirement is not met if a claim is narrowed by an amendment that adds an element or limitation that is not supported by the specification). |
| [88] | Thomas E. Fisher, Dealing with Sections 102 and 112, 258 Prac. L. Inst. 453, 463 (Nov. 1988). |
| [89] | See id. |
| [90] | 134 F.3d 1473, 1479 (Fed. Cir. 1998). |
| [91] | See id.; see also Regents of the University of California v. Eli Lilly & Co., 119 F.3d 1559, 1568 (Fed. Cir. 1997); Wang Laboratories, Inc. v. Toshiba Corp., 993 F.2d 858 (Fed. Cir. 1993); In re Kaslow, 707 F.2d 1366 (Fed. Cir. 1983). |
| [92] | Fisher, supra note 88, at 463. |
| [93] | See id. |
| [94] | See id.; see also In re Smythe, 480 F.2d 1376, 1382 (C.C.P.A. 1973). |
| [95] | Fisher, supra note 88, at 463. |
| [96] | Id.; see also Tronzo v. Biomet Inc., 156 F. Supp. 1154, 1154 (Fed. Cir. 1998) (stating that the written decription test can be satisfied by an inherent disclosure of the invention so long as the inventor's possession of the claimed invention is obvious); Ralston Purina Co. v. Far-Mar-Co., Inc., 772 F.2d 1570, 1574-75 (Fed. Cir. 1985); In re Smythe, 480 F.2d at 1384. |
| [97] | Interview with Martin J. O'Donnell, Esq., Partner, Cesari and McKenna, LLP (May, 2001). |
| [98] | See Markman v. Westview Instruments, Inc., 517 U.S. 370, 373-74 (1996). |
| [99] | Ralston Purina Co. v. Far-Mar-Co., Inc., 772 F.2d 1570, 1575 (Fed. Cir. 1985). |
© 2002 Mark R. Goldschmidt. Published with permission of the copyright holder.